subject: MESH:C079198

subject_name: S 1 (combination)

object_name: classic complement early component deficiency


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

tested_intervention: unsure


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: PUBCHEM.COMPOUND:160883

subject_name: Butylscopolamine

object_name: Acute abdomen


subject: CHEBI:35480

subject_name: analgesic


subject: UMLS:C4722089

subject_name: Analgesics [TC]


subject: UMLS:C1831967

object_name: prostate carcinoma

tested_intervention: yes


subject: UMLS:C1831967

object_name: prostate cancer


subject: UMLS:C1831967

object_name: ovarian cancer


subject: UMLS:C1831967

object_name: ovarian neoplasm


subject: UMLS:C1831967

object_name: ovarian carcinoma


subject: UMLS:C1831967

object_name: Childhood Breast Carcinoma


subject: UMLS:C1831967

object_name: breast carcinoma


subject: UMLS:C1831967

object_name: breast cancer


subject: UMLS:C1831967

object_name: renal carcinoma


subject: UMLS:C1831967

object_name: kidney cancer


subject: UMLS:C1831967

object_name: colon carcinoma


subject: UMLS:C1831967

object_name: colorectal cancer


subject: UMLS:C1831967

object_name: colon cancer


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Prostatic Cancer, Castration-Resistant


subject: UMLS:C3827082


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:95089

subject_name: Ipatasertib


subject: CHEBI:47808

subject_name: Sulforaphane

object_name: Depressed mood


subject: UNII:T4RS462G19

subject_name: Almonertinib

object_name: Epidermal growth factor receptor positive non-small cell lung cancer


subject: UMLS:C2366367

subject_name: Cinryze

object_name: Graft Rejection


subject: UMLS:C0540301

subject_name: C1 esterase inhibitor


subject: UMLS:C0009500

subject_name: Complement C1 Inactivator Proteins


subject: PR:000014707

subject_name: plasma protease C1 inhibitor


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: Stage III Uterine Corpus Cancer AJCC v8


subject: GTOPDB:9592

object_name: Stage III Pancreatic Cancer AJCC v8


subject: GTOPDB:9592

object_name: Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8


subject: GTOPDB:9592

object_name: Stage III Lung Cancer AJCC v8


subject: GTOPDB:9592

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: GTOPDB:9592

object_name: Stage III Testicular Cancer AJCC v6 and v7


subject: GTOPDB:9592

object_name: Stage III Renal Cell Cancer AJCC v8


subject: GTOPDB:9592

object_name: Masaoka-Koga Stage III


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:68551

subject_name: Linaclotide

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan

object_name: malignant neoplasm of breast stage IV


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UMLS:C3640943


subject: CHEBI:231683

subject_name: Anakinra

object_name: neuroinflammatory response


subject: CHEBI:231683

object_name: Endotoxemia


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: PR:000001137


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: UNII:I031V2H011


subject: UMLS:C0935902

object_name: Childhood Breast Carcinoma


subject: UMLS:C0935902

object_name: breast carcinoma


subject: UMLS:C0935902

object_name: breast cancer


subject: UMLS:C1831875

subject_name: urelumab

object_name: non-small cell lung carcinoma


subject: UMLS:C1869412

object_name: neoplasm


subject: CHEBI:16755

subject_name: chenodiol

object_name: type 2 diabetes mellitus


subject: CHEBI:16755

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:16755

object_name: obesity


subject: CHEBI:16755

object_name: Obesity, CTCAE


subject: CHEBI:59594

subject_name: Colesevelam


subject: CHEBI:59594


subject: CHEBI:59594


subject: CHEBI:31587

subject_name: Exatecan mesilate hydrate

object_name: Stomach cancer


subject: CHEBI:31587

object_name: gastric cancer


subject: CHEBI:31587

object_name: carcinoma of esophagus


subject: CHEBI:31587

object_name: esophageal cancer


subject: CHEBI:31587

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:31587

object_name: neoplasm of esophagus


subject: CHEBI:135709

subject_name: Exatecan


subject: CHEBI:135709


subject: CHEBI:135709


subject: CHEBI:135709


subject: CHEBI:135709


subject: CHEBI:135709


subject: UMLS:C0935945

subject_name: exatecan mesylate


subject: UMLS:C0935945


subject: UMLS:C0935945


subject: UMLS:C0935945


subject: UMLS:C0935945


subject: UMLS:C0935945


subject: PUBCHEM.COMPOUND:2171

object_name: Cow milk allergy


subject: UMLS:C0591081

subject_name: Amix


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:60799

subject_name: Esketamine

object_name: fibromyalgia


subject: MESH:C433370

subject_name: Traumeel S

object_name: hip fracture


subject: PR:000013374

subject_name: proteasome subunit beta type-6

object_name: ulcerative colitis


subject: PR:000013374

object_name: inflammatory bowel disease 1


subject: CHEBI:73024

subject_name: O-acetylcarnitine


subject: CHEBI:57589

subject_name: Acetylcarnitine


subject: UMLS:C5854391

subject_name: Lucorafusp Alfa

object_name: pancreatic neoplasm


subject: UMLS:C5854391

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5854391

object_name: malignant pancreatic neoplasm


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UMLS:C1948073


subject: CHEBI:9123

subject_name: Sertraline

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:9123

object_name: obesity


subject: CHEBI:9123

object_name: Obesity, CTCAE


subject: CHEBI:92110

subject_name: telenzepine


subject: CHEBI:92110


subject: CHEBI:92110


subject: CHEBI:5613

subject_name: Haloperidol

object_name: Headache


subject: CHEBI:5613

object_name: Headache, CTCAE


subject: CHEBI:64816

object_name: Malignant neoplasm of female breast


subject: CHEBI:64816

object_name: doxorubicin induced cardiomyopathy


subject: CHEBI:64816

object_name: Cardiomyopathy secondary to doxorubicin administration


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:73727


subject: CHEBI:73727


subject: CHEBI:73727


subject: CHEBI:7465

subject_name: Naltrexone

object_name: Back Pain, CTCAE 5.0


subject: CHEBI:7465

object_name: Back pain


subject: CHEBI:7465

object_name: Back Pain, CTCAE 3.0


subject: CHEBI:7465

object_name: Neck pain


subject: CHEBI:7465

object_name: Low back pain


subject: RXCUI:605343

subject_name: Synera

object_name: Anesthesia of mucous membrane


subject: CHEBI:38940

subject_name: Sunitinib

object_name: B-cell chronic lymphocytic leukemia


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: BRCA Hereditary Breast Carcinoma


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UNII:768FW21J3L

subject_name: Famitinib


subject: DRUGBANK:DB18703

object_name: Her2-receptor negative breast cancer


subject: DRUGBANK:DB18703


subject: UNII:14C97E680P

subject_name: Wheat germ oil

object_name: Deficiency of vitamin D3


subject: CHEMBL.COMPOUND:CHEMBL2109583

object_name: non-small cell lung carcinoma


subject: UMLS:C2984216

subject_name: F16-IL2 Fusion Protein


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22

object_name: head and neck squamous cell carcinoma


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: CHEBI:27732

subject_name: Caffeine

object_name: Sleep Inertia


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Caesarean section


subject: CHEBI:82941

subject_name: Fosamprenavir

object_name: hepatitis C


subject: CHEBI:29321

subject_name: sodium nitroprusside

object_name: Vasodilation disorder


subject: CHEBI:29321

object_name: Pathologic vasoconstriction


subject: CHEBI:29321

object_name: Vasoconstriction


subject: UNII:EAO03PE1TC

subject_name: Sodium nitroprusside hydrate


subject: UNII:EAO03PE1TC


subject: UNII:EAO03PE1TC


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: CHEBI:36791

subject_name: Escitalopram

object_name: Depressive Syndrome


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:4975

subject_name: Famotidine

object_name: dyspepsia


subject: CHEBI:4975

object_name: Dyspepsia, CTCAE


subject: CHEBI:15407

subject_name: Ephedrine

object_name: Hemodynamic instability


subject: CHEBI:8093

subject_name: Phenylephrine


subject: CHEBI:177594

subject_name: Uracil C-13

object_name: gastroparesis


subject: CHEBI:177594

object_name: Gastroparesis, CTCAE


subject: CHEBI:72690

subject_name: Pomalidomide

object_name: corneal disease


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: neuroendocrine neoplasm


subject: UNII:52CMI0WC3Y

object_name: vulva cancer


subject: UNII:52CMI0WC3Y

object_name: vulva carcinoma


subject: UNII:52CMI0WC3Y

object_name: bile duct carcinoma


subject: UNII:52CMI0WC3Y

object_name: bile duct cancer


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: CHEBI:91327

subject_name: Tivozanib

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:91327

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:91327

object_name: sarcoma


subject: CHEBI:91327

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:91327

object_name: soft tissue sarcoma


subject: CHEBI:91327

object_name: Childhood Breast Carcinoma


subject: CHEBI:91327

object_name: breast carcinoma


subject: CHEBI:91327

object_name: breast cancer


subject: CHEBI:91327


subject: CHEBI:91327


subject: CHEBI:91327


subject: CHEBI:91327

object_name: ovarian cancer


subject: CHEBI:91327

object_name: ovarian neoplasm


subject: CHEBI:91327

object_name: ovarian carcinoma


subject: CHEBI:91327


subject: CHEBI:91327


subject: CHEBI:91327

object_name: pancreatic adenocarcinoma


subject: CHEBI:91327

object_name: gallbladder cancer


subject: CHEBI:15365

subject_name: Aspirin

object_name: chronic kidney disease


subject: CHEMBL.COMPOUND:CHEMBL2219773

subject_name: CUSTIRSEN SODIUM

object_name: non-small cell lung carcinoma


subject: UNII:37CQ2C7X93

subject_name: Canakinumab

object_name: atrial fibrillation


subject: UNII:37CQ2C7X93

object_name: Atrial Fibrillation by ECG Finding


subject: UNII:37CQ2C7X93

object_name: Atrial Fibrillation, CTCAE


subject: UMLS:C2718754

subject_name: Ilaris


subject: UMLS:C2718754


subject: UMLS:C2718754


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: Bone fracture


subject: UNII:6XC1PAD3KF

object_name: Fractured


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: UNII:D652ZWF066

subject_name: sodium zirconium cyclosilicate

object_name: Type 2 diabetes mellitus with kidney complications


subject: UNII:5MEI1M3NHH

object_name: schizophrenia


subject: CHEBI:61080

subject_name: Romidepsin

object_name: renal pelvis/ureter urothelial carcinoma


subject: CHEBI:61080

object_name: carcinoma of urethra


subject: CHEBI:61080

object_name: urethra cancer


subject: UMLS:C4082795

subject_name: Depsipeptide Antineoplastic Antibiotic


subject: UMLS:C4082795


subject: UMLS:C4082795


subject: UMLS:C4082795

object_name: bladder tumor


subject: UMLS:C4082795

object_name: urinary bladder carcinoma


subject: UMLS:C4082795

object_name: urinary bladder cancer


subject: UMLS:C4082795

object_name: childhood bladder carcinoma


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0796678

subject_name: Depsipeptides


subject: UMLS:C0796678


subject: UMLS:C0796678


subject: UMLS:C0796678


subject: UMLS:C0796678


subject: UMLS:C0796678


subject: UMLS:C0796678


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: Tremor


subject: CHEBI:26710

object_name: Tremor, CTCAE_5


subject: CHEBI:26710

object_name: Tremor, CTCAE_3


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:5281767

object_name: primary cutaneous T-cell lymphoma


subject: PUBCHEM.COMPOUND:131751561

subject_name: Cyclostenol


subject: PUBCHEM.COMPOUND:131751561


subject: DRUGBANK:DB14276

subject_name: Turmeric


subject: DRUGBANK:DB14276


subject: CHEBI:3374

subject_name: Capsaicin

object_name: myofascial pain syndrome


subject: CHEBI:3374

object_name: fibromyalgia


subject: UMLS:C4725753

subject_name: Vudalimab

object_name: head and neck squamous cell carcinoma


subject: UMLS:C4725753

object_name: castration-resistant prostate carcinoma


subject: UMLS:C4725753

object_name: squamous cell carcinoma of penis


subject: UMLS:C4725753

object_name: anal squamous cell carcinoma


subject: UMLS:C4725753

object_name: non-small cell lung carcinoma


subject: UMLS:C4725753

object_name: nasopharyngeal carcinoma


subject: UMLS:C4725753

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UMLS:C4725753

object_name: fallopian tube carcinoma


subject: UMLS:C4725753

object_name: urothelial carcinoma


subject: UMLS:C4725753

object_name: transitional cell carcinoma


subject: UMLS:C4725753

object_name: basal cell carcinoma


subject: UMLS:C4725753

object_name: skin basal cell carcinoma


subject: UMLS:C4725753

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C4725753

object_name: clear cell renal carcinoma


subject: UMLS:C4725753

object_name: renal cell adenocarcinoma


subject: UMLS:C4725753

object_name: renal cell carcinoma


subject: UMLS:C4725753

object_name: cholangiocarcinoma


subject: UMLS:C4725753

object_name: cervical cancer


subject: UMLS:C4725753

object_name: malignant epithelial tumor of ovary


subject: UMLS:C4725753

object_name: type C thymoma


subject: UMLS:C4725753

object_name: vulva carcinoma


subject: UMLS:C4725753

object_name: breast carcinoma


subject: UMLS:C4725753

object_name: Mesothelioma


subject: UMLS:C4725753

object_name: mesothelial neoplasm


subject: UMLS:C4725753

object_name: malignant mesothelioma


subject: UMLS:C4725753

object_name: melanoma


subject: UMLS:C4725753

object_name: thymoma


subject: UMLS:C4725753

object_name: thymus neoplasm


subject: CHEBI:3011

subject_name: Benazepril

object_name: chronic kidney disease


subject: UNII:R96TV84T21

subject_name: CENICRIVIROC MESYLATE

object_name: HIV infection


subject: UMLS:C5418326

subject_name: Cenicriviroc Mesylate


subject: UNII:W9Y8L7GP4C

subject_name: Cetrotide

object_name: Androgen excess


subject: UMLS:C0872997

subject_name: SB 075 Acetate


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: persistent atrial fibrillation


subject: UNII:UC95NQ339C

object_name: Persistent Atrial Fibrillation by ECG Finding


subject: UNII:UC95NQ339C

object_name: paroxysmal atrial fibrillation


subject: UNII:UC95NQ339C

object_name: Paroxysmal Atrial Fibrillation by ECG Finding


subject: UMLS:C0006055

subject_name: Botulinum Toxins


subject: UMLS:C0006055


subject: UMLS:C0006055


subject: UMLS:C0006055


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: systolic heart failure


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Recurrent Skin Carcinoma


subject: UMLS:C0879636

subject_name: IMC C225


subject: CHEBI:92511

subject_name: Ketotifen

object_name: Nonulcer dyspepsia


subject: CHEBI:134512

object_name: liver carcinoma


subject: UMLS:C2703096

object_name: anus neoplasm


subject: UMLS:C1328728


subject: CHEBI:82978

subject_name: paliperidone

object_name: Suicidal ideation


subject: CHEBI:82978

object_name: Suicidal Ideation, CTCAE


subject: CHEBI:82978

object_name: endogenous depression


subject: CHEBI:82978

object_name: major depressive disorder


subject: CHEBI:188072


subject: CHEBI:188072


subject: CHEBI:188072


subject: CHEBI:188072


subject: CHEBI:83804

subject_name: Paliperidone


subject: CHEBI:83804


subject: CHEBI:83804


subject: CHEBI:83804


subject: UMLS:C4329329

object_name: ovarian cancer


subject: UMLS:C4329329

object_name: ovarian carcinoma


subject: UMLS:C4329329

object_name: malignant epithelial tumor of ovary


subject: UMLS:C4329329

object_name: primary peritoneal carcinoma


subject: UMLS:C4329329

object_name: papillary serous cystadenocarcinoma


subject: UMLS:C4329329

object_name: peritoneal carcinoma


subject: UMLS:C4329329

object_name: fallopian tube carcinoma


subject: UMLS:C0042210

subject_name: Vaccines

object_name: kidney failure


subject: UMLS:C0042210

object_name: Renal Failure, CTCAE


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5399710


subject: PUBCHEM.COMPOUND:78140854

subject_name: Ivosidenib

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Fumarate Hydratase-Deficient Renal Cell Carcinoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: CHEBI:174348

object_name: infertility


subject: CHEBI:6717

subject_name: Mefenamic acid


subject: CHEBI:91541


subject: UNII:I5I8VB78VT

subject_name: Erenumab

object_name: Transformed migraine


subject: UNII:TX3R141LEP

object_name: herpes zoster


subject: UNII:TX3R141LEP

object_name: postherpetic neuralgia


subject: UMLS:C1875126

subject_name: ESTROGENS,VAGINAL

object_name: pelvic organ prolapse


subject: UNII:GN429E725A

subject_name: Nedisertib

object_name: Advanced Head and Neck Squamous Cell Carcinoma


subject: UNII:GN429E725A

object_name: Advanced Laryngeal Squamous Cell Carcinoma


subject: UNII:GN429E725A

object_name: Advanced Oral Cavity Squamous Cell Carcinoma


subject: UNII:GN429E725A

object_name: Advanced Oropharyngeal Squamous Cell Carcinoma


subject: UNII:GN429E725A

object_name: Advanced Hypopharyngeal Squamous Cell Carcinoma


subject: UNII:GN429E725A

object_name: Stage IVB Hypopharyngeal Carcinoma AJCC v8


subject: UNII:GN429E725A

object_name: Stage III Hypopharyngeal Carcinoma AJCC v8


subject: UNII:GN429E725A

object_name: Stage IVA Hypopharyngeal Carcinoma AJCC v8


subject: UNII:GN429E725A

object_name: Stage IVB Laryngeal Cancer AJCC v8


subject: UNII:GN429E725A

object_name: Stage III Laryngeal Cancer AJCC v8


subject: UNII:GN429E725A

object_name: Stage IVA Laryngeal Cancer AJCC v8


subject: UNII:GN429E725A

object_name: Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: UNII:GN429E725A

object_name: Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: UNII:GN429E725A

object_name: Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: UNII:GN429E725A

object_name: Stage III Lip and Oral Cavity Cancer AJCC v8


subject: UNII:GN429E725A

object_name: Stage IVA Lip and Oral Cavity Cancer AJCC v8


subject: UNII:GN429E725A

object_name: Stage IVB Lip and Oral Cavity Cancer AJCC v8


subject: UNII:GN429E725A

object_name: Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UMLS:C0003195

subject_name: Anti-Arrhythmia Agents

object_name: Arrhythmia


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: autoimmune hepatitis


subject: UNII:UQ6CV583Q3

subject_name: FLUCICLATIDE

object_name: nonpapillary renal cell carcinoma


subject: UNII:UQ6CV583Q3

object_name: clear cell renal carcinoma


subject: UNII:UQ6CV583Q3

object_name: renal cell adenocarcinoma


subject: UNII:UQ6CV583Q3

object_name: renal cell carcinoma


subject: UNII:UQ6CV583Q3

object_name: uterine cancer


subject: UNII:UQ6CV583Q3

object_name: tumor of uterus


subject: UNII:UQ6CV583Q3

object_name: cervical cancer


subject: UNII:UQ6CV583Q3

object_name: cervical carcinoma


subject: UNII:UQ6CV583Q3

object_name: lung cancer


subject: UNII:UQ6CV583Q3

object_name: lung neoplasm


subject: UNII:UQ6CV583Q3

object_name: lung carcinoma


subject: UNII:UQ6CV583Q3

object_name: colon carcinoma


subject: UNII:UQ6CV583Q3

object_name: colorectal cancer


subject: UNII:UQ6CV583Q3

object_name: colon cancer


subject: UMLS:C4045542

subject_name: Fluciclatide


subject: UMLS:C4045542


subject: UMLS:C4045542


subject: UMLS:C4045542


subject: UMLS:C4045542


subject: UMLS:C4045542


subject: UMLS:C4045542


subject: UMLS:C4045542


subject: UMLS:C4045542


subject: UMLS:C4045542


subject: UMLS:C4045542


subject: UMLS:C4045542


subject: UMLS:C4045542


subject: UMLS:C4045542


subject: MESH:C557247

subject_name: oxycodone naloxone combination

object_name: chronic pain (diagnosis)


subject: MESH:C557247

object_name: Chronic pain


subject: MESH:D002136

subject_name: Calcium, Dietary

object_name: Growth & development aspects


subject: MESH:D002136

object_name: Burn injury


subject: MESH:D002136

object_name: Burn, CTCAE


subject: MESH:D002136

object_name: malnutrition


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UMLS:C3540037


subject: UMLS:C3540037


subject: UMLS:C3540037


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: UNII:WY779SQ0XW


subject: UNII:WY779SQ0XW


subject: UNII:WY779SQ0XW


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:29108


subject: CHEBI:29108


subject: CHEBI:29108


subject: CHEBI:22984

subject_name: Calcium


subject: CHEBI:22984


subject: CHEBI:22984


subject: CHEBI:22984


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C2936886


subject: UMLS:C2936886


subject: UMLS:C2936886


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: UMLS:C3714611


subject: UMLS:C3714611


subject: UMLS:C3714611


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: CHEBI:89324


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: CHEBI:6456

subject_name: Lidocaine

object_name: diabetic neuropathy


subject: UMLS:C2958908

subject_name: Injection, denosumab, 1 mg administered

object_name: postmenopausal osteoporosis


subject: UMLS:C5203422

subject_name: Denosumab Liquid Injection


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Metastatic Kidney Carcinoma


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UNII:LE6Z74KA8H

object_name: osteoarthritis, knee


subject: UNII:LE6Z74KA8H

object_name: Chronic low back pain


subject: UMLS:C5401611

subject_name: Washed Microbiota Transplantation

object_name: rhinitis


subject: CHEBI:125427

object_name: Thyroid nodule


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: CHEBI:17823

subject_name: Calcitriol


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: glioblastoma


subject: UNII:KXG2PJ551I

object_name: Childhood Glioblastoma


subject: UNII:KXG2PJ551I

object_name: adult glioblastoma


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: CHEBI:74538

subject_name: Leu-Gly-Gly

object_name: influenza


subject: UMLS:C0721277

subject_name: LGG brand of Dyphylline/Guaifenesin


subject: UMLS:C1832078

subject_name: LGG Lactobacillus rhamnosus GG


subject: UMLS:C0699320

subject_name: Endoxan

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UMLS:C0699320

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:49200

subject_name: EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor

object_name: Peptic Ulcer Hemorrhage


subject: UMLS:C0358591

subject_name: Proton Pump Inhibitors


subject: UMLS:C3536754

subject_name: Proton Pump Inhibitor [EPC]


subject: CHEBI:6375

subject_name: Lansoprazole


subject: CHEBI:90623

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:90623

object_name: myelofibrosis


subject: CHEBI:90623

object_name: acute myeloid leukemia


subject: CHEBI:90620

subject_name: Vatalanib


subject: CHEBI:90620


subject: CHEBI:90620


subject: UMLS:C0912413

subject_name: PTK 787


subject: UMLS:C0912413


subject: UMLS:C0912413


subject: UMLS:C5690696

subject_name: MitoQ

object_name: mild neurocognitive disorder


subject: UMLS:C5690696

object_name: mild cognitive impairment


subject: UMLS:C5690696

object_name: Alzheimer Disease, Early Onset


subject: CHEBI:75551

object_name: Rest limb pain


subject: CHEBI:37941

subject_name: Clopidogrel


subject: UMLS:C4054948

subject_name: Pegloprastide

object_name: Childhood Breast Carcinoma


subject: UMLS:C4054948

object_name: breast cancer


subject: UNII:2QN49PWH71

subject_name: benzylmandelate

object_name: Incontinence


subject: UNII:2QN49PWH71

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:2QN49PWH71

object_name: obesity


subject: UNII:2QN49PWH71

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:5284632

subject_name: Trospium


subject: PUBCHEM.COMPOUND:5284632


subject: PUBCHEM.COMPOUND:5284632


subject: PUBCHEM.COMPOUND:5284632


subject: PR:000017503

subject_name: solute carrier family 53 member 1


subject: PR:000017503

object_name: Urinary Urgency


subject: PR:000017503


subject: PR:000017503


subject: PR:000017503


subject: PR:000006336

subject_name: L-xylulose reductase


subject: PR:000006336


subject: PR:000006336


subject: PR:000006336


subject: PR:000006336


subject: MESH:C500223

subject_name: lycium barbarum polysaccharide

object_name: Depressive Symptoms


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Compulsion


subject: RXCUI:659877

subject_name: Gardasil

object_name: Human Papilloma Virus, Female


subject: RXCUI:659877

object_name: Human Papilloma Virus, Male


subject: UMLS:C3853661

subject_name: Artificial Tears

object_name: xerophthalmia


subject: UMLS:C1720919

subject_name: Zostavax

object_name: EXCESS LMW-DNA


subject: CHEBI:17933

subject_name: Calcifediol

object_name: cardiovascular disorder


subject: CHEBI:8499

subject_name: Propranolol

object_name: Syncope Related to COVID-19


subject: CHEBI:8499

object_name: Syncope, CTCAE 5.0


subject: CHEBI:8499

object_name: Syncope


subject: CHEBI:125628

subject_name: Alisertib

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: UNII:9G6U5L461Q

subject_name: Icotinib

object_name: Disseminated Malignant Neoplasm


subject: UNII:9G6U5L461Q

object_name: Embolism, Tumor


subject: UNII:9G6U5L461Q

object_name: Neoplasm Metastasis


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Adult Giant Cell Glioblastoma


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: Recurrent Adult Brain Neoplasm


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: CHEBI:125482

subject_name: Nitroaspirin

object_name: colorectal cancer


subject: CHEBI:125482

object_name: colorectal carcinoma


subject: CHEBI:125482

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:6504

object_name: stroke disorder


subject: CHEBI:6504

object_name: cerebrovascular disorder


subject: CHEBI:6504

object_name: Stroke (heart beat)


subject: CHEBI:6504

object_name: Stroke, CTCAE


subject: GTOPDB:13443

object_name: Stomach cancer


subject: GTOPDB:13443

object_name: gastric cancer


subject: UMLS:C5417907

subject_name: Anti-HER2 Monoclonal Antibody HLX22


subject: UMLS:C5417907


subject: UNII:702RHR475O

subject_name: FOSBRETABULIN DISODIUM

object_name: Neck Carcinoma


subject: UNII:702RHR475O

object_name: head and neck neoplasm


subject: UNII:702RHR475O

object_name: head and neck cancer


subject: UMLS:C0962508

subject_name: combretastatin A-4 disodium phosphate


subject: UMLS:C0962508


subject: UMLS:C0962508


subject: UNII:2946IE3VYD

object_name: leukemia


subject: UNII:2946IE3VYD

object_name: childhood leukemia


subject: UNII:2946IE3VYD

object_name: Recurrent Acute Myeloid Leukemia


subject: UNII:2946IE3VYD

object_name: Refractory Acute Lymphoblastic Leukemia


subject: UNII:2946IE3VYD

object_name: Acute lymphoblastic leukemia recurrent


subject: UNII:2946IE3VYD

object_name: acute biphenotypic leukemia


subject: UNII:2946IE3VYD

object_name: mixed phenotype acute leukemia


subject: UNII:2946IE3VYD

object_name: acute leukemia of ambiguous lineage


subject: UNII:2946IE3VYD

object_name: acute biphenotypic leukemia in relapse


subject: UNII:2946IE3VYD

object_name: acute undifferentiated leukemia in relapse


subject: UNII:2946IE3VYD

object_name: Recurrent Mixed Phenotype Acute Leukemia


subject: UNII:2946IE3VYD

object_name: recurrent childhood acute myeloid leukemia


subject: UNII:2946IE3VYD

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: UNII:2946IE3VYD

object_name: Infant Acute Biphenotypic Leukemia


subject: UNII:2946IE3VYD

object_name: Refractory Myelodysplastic Syndrome


subject: UNII:2946IE3VYD

object_name: Recurrent Chronic Myelomonocytic Leukemia


subject: UNII:2946IE3VYD

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UNII:2946IE3VYD

object_name: Infant Acute Undifferentiated Leukemia


subject: UNII:2946IE3VYD

object_name: acute undifferentiated leukemia


subject: UNII:2946IE3VYD

object_name: Recurrent Myelodysplastic Syndrome


subject: UNII:2946IE3VYD

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: UNII:2946IE3VYD

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UNII:2946IE3VYD

object_name: Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm


subject: UNII:2946IE3VYD

object_name: juvenile myelomonocytic leukemia


subject: UNII:2946IE3VYD

object_name: chronic myelomonocytic leukemia


subject: UNII:2946IE3VYD

object_name: Blast Phase


subject: UNII:2946IE3VYD

object_name: Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm


subject: UNII:2946IE3VYD

object_name: Adult Myelodysplastic Syndrome


subject: UNII:2946IE3VYD

object_name: childhood myelodysplastic syndrome


subject: UNII:2946IE3VYD

object_name: Myelodysplastic Syndrome, CTCAE


subject: UNII:2946IE3VYD

object_name: Neoplasm, Residual


subject: MESH:D016827

subject_name: CD8 Antigens

object_name: leukemia


subject: MESH:D016827

object_name: childhood leukemia


subject: MESH:D016827

object_name: Recurrent Acute Myeloid Leukemia


subject: MESH:D016827

object_name: Refractory Acute Lymphoblastic Leukemia


subject: MESH:D016827

object_name: Acute lymphoblastic leukemia recurrent


subject: MESH:D016827

object_name: acute biphenotypic leukemia


subject: MESH:D016827

object_name: mixed phenotype acute leukemia


subject: MESH:D016827

object_name: acute leukemia of ambiguous lineage


subject: MESH:D016827

object_name: acute biphenotypic leukemia in relapse


subject: MESH:D016827

object_name: acute undifferentiated leukemia in relapse


subject: MESH:D016827

object_name: Recurrent Mixed Phenotype Acute Leukemia


subject: MESH:D016827

object_name: recurrent childhood acute myeloid leukemia


subject: MESH:D016827

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: MESH:D016827

object_name: Infant Acute Biphenotypic Leukemia


subject: MESH:D016827

object_name: Refractory Myelodysplastic Syndrome


subject: MESH:D016827

object_name: Recurrent Chronic Myelomonocytic Leukemia


subject: MESH:D016827

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: MESH:D016827

object_name: Infant Acute Undifferentiated Leukemia


subject: MESH:D016827

object_name: acute undifferentiated leukemia


subject: MESH:D016827

object_name: Recurrent Myelodysplastic Syndrome


subject: MESH:D016827

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: MESH:D016827

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: MESH:D016827

object_name: Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm


subject: MESH:D016827

object_name: juvenile myelomonocytic leukemia


subject: MESH:D016827

object_name: chronic myelomonocytic leukemia


subject: MESH:D016827

object_name: Blast Phase


subject: MESH:D016827

object_name: Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm


subject: MESH:D016827

object_name: Adult Myelodysplastic Syndrome


subject: MESH:D016827

object_name: childhood myelodysplastic syndrome


subject: MESH:D016827

object_name: Myelodysplastic Syndrome, CTCAE


subject: MESH:D016827

object_name: Neoplasm, Residual


subject: CHEBI:6121

subject_name: Ketamine

object_name: choledocholithiasis


subject: CHEBI:6121

object_name: Choledocholithiasis


subject: CHEBI:6121

object_name: bile duct cyst


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: postpoliomyelitis syndrome


subject: CHEBI:32010

subject_name: Piracetam


subject: CHEBI:52970

object_name: heart failure


subject: CHEBI:52970

object_name: Heart Failure, CTCAE


subject: CHEBI:60899


subject: CHEBI:60899


subject: CHEBI:177490


subject: CHEBI:177490


subject: CHEBI:167578


subject: CHEBI:167578


subject: CHEBI:64183

subject_name: Ubiquinol


subject: CHEBI:64183


subject: UMLS:C0243043

subject_name: Heat-Shock Proteins 70

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C0243043


subject: UMLS:C2713594

subject_name: gallium-68 DOTATOC

object_name: neuroendocrine neoplasm


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: hypertension, pregnancy-induced


subject: CHEBI:85078

object_name: Maternal hypertension


subject: CHEBI:85078

object_name: Cardiac complication


subject: CHEBI:85078

object_name: preeclampsia


subject: CHEBI:85078

object_name: Pre-eclampsia added to pre-existing hypertension


subject: UMLS:C2064756

subject_name: regional anesthetics

object_name: Control of hip fracture risk


subject: UMLS:C2064756

object_name: hip fracture


subject: UMLS:C2064756

object_name: Post-Operative Pain


subject: UMLS:C2064756

object_name: opioid use


subject: UMLS:C2064756

object_name: pain agnosia


subject: UMLS:C2064756

object_name: Pain insensitivity


subject: UMLS:C0009905

subject_name: Contraceptives, Oral

object_name: Abnormal uterine bleeding


subject: UMLS:C0009905

object_name: Scarring of uterus


subject: UMLS:C0009905

object_name: cesarean section; complications


subject: CHEBI:18248

subject_name: Iron

object_name: Helicobacter pylori infection


subject: CHEBI:29034

subject_name: Ferric cation


subject: UMLS:C1166521

subject_name: Ferrum metallicum, Homeopathic preparation


subject: UMLS:C3714701

subject_name: Iron Drug Class


subject: UMLS:C5706326

subject_name: SPR 001

object_name: classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol

object_name: Hot Flashes, CTCAE


subject: PUBCHEM.COMPOUND:3080587

object_name: Hot flashes


subject: UMLS:C4725106

subject_name: PI3K-d Inhibitor HMPL 689

object_name: adult lymphoma


subject: UMLS:C4725106

object_name: lymphoma


subject: UMLS:C4725106

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:4240

subject_name: Mometasone furoate

object_name: Rhinitis medicamentosa


subject: CHEBI:6970

subject_name: Mometasone


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: diabetes mellitus


subject: GTOPDB:13792

subject_name: iparomlimab

object_name: malignant mesothelioma


subject: GTOPDB:13792

object_name: Mesothelioma


subject: GTOPDB:13792

object_name: mesothelial neoplasm


subject: UNII:FN3VWV28BC

subject_name: IPAROMLIMAB


subject: UNII:FN3VWV28BC


subject: UNII:FN3VWV28BC


subject: UMLS:C5669553

subject_name: Iparomlimab


subject: UMLS:C5669553


subject: UMLS:C5669553


subject: GTOPDB:13793

subject_name: tuvonralimab


subject: GTOPDB:13793


subject: GTOPDB:13793


subject: UNII:8XWO7LI4LO

subject_name: TUVONRALIMAB


subject: UNII:8XWO7LI4LO


subject: UNII:8XWO7LI4LO


subject: UMLS:C5784793

subject_name: Tuvonralimab


subject: UMLS:C5784793


subject: UMLS:C5784793


subject: UMLS:C4053581

object_name: Pancreatic adenocarcinoma metastatic


subject: UMLS:C5854510

subject_name: Recombinant Albumin-binding IL-12 SON-1010

object_name: Well adult


subject: CHEBI:131854

subject_name: Fotemustine

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:92076

subject_name: AFIMOXIFENE

object_name: estrogen-receptor positive breast cancer


subject: UNII:TRI2520XBJ

object_name: hypertension


subject: UNII:TRI2520XBJ

object_name: Hypertension, CTCAE


subject: UMLS:C1161331

subject_name: Saccharum officinale, sucrose, cane sugar, Homeopathic preparation

object_name: pain agnosia


subject: UMLS:C1161331

object_name: Pain insensitivity


subject: CHEBI:17992

subject_name: Sucrose


subject: CHEBI:17992


subject: CHEBI:26708

subject_name: sodium atom

object_name: urolithiasis


subject: CHEBI:26708

object_name: nephrolithiasis


subject: CHEBI:29101

subject_name: Sodium cation


subject: CHEBI:29101


subject: UMLS:C3541959

subject_name: Sodium supplements


subject: UMLS:C3541959


subject: UMLS:C3714642

subject_name: Sodium Drug Class


subject: UMLS:C3714642


subject: UMLS:C4733725

subject_name: Algae extract

object_name: Stress


subject: CHEBI:40968

subject_name: Astaxanthin


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: UMLS:C0304395

subject_name: marijuana derivative

object_name: endometriosis


subject: UMLS:C0304395

object_name: pelvic pain on the left


subject: UMLS:C0304395

object_name: pelvic pain occurs with urination


subject: UMLS:C0304395

object_name: pelvic pain occurs with bowel movement


subject: UMLS:C0304395

object_name: pelvic pain decreasing in severity


subject: UMLS:C0304395

object_name: Pelvic pain female


subject: UMLS:C0304395

object_name: pelvic pain increasing in severity


subject: UMLS:C0304395

object_name: male pelvic pain


subject: UMLS:C0304395

object_name: pelvic pain to the rear


subject: UMLS:C0304395

object_name: pelvic pain on the right


subject: UMLS:C0304395

object_name: pelvic pain decreasing in frequency


subject: UMLS:C0304395

object_name: Pelvic pain


subject: UMLS:C0304395

object_name: Pelvic Pain, CTCAE 5.0


subject: UMLS:C0304395

object_name: pelvic pain causes awakening at night


subject: UMLS:C0304395

object_name: pelvic pain increasing in frequency


subject: UMLS:C0304395

object_name: pelvic pain occurs with intercourse


subject: UMLS:C0304395

object_name: pelvic pain in front


subject: CHEBI:27504

subject_name: Mitomycin

object_name: Corneal opacity


subject: CHEBI:74947

subject_name: Thalidomide

object_name: metastatic colorectal cancer


subject: CHEBI:51209

subject_name: Pseudoephedrine

object_name: Hay fever


subject: MESH:D017077

subject_name: Culture Media, Conditioned

object_name: retinitis pigmentosa


subject: MESH:D017077

object_name: retinitis pigmentosa 1


subject: UNII:IY90U61Z3S

subject_name: ARGATROBAN

object_name: stroke disorder


subject: UNII:IY90U61Z3S

object_name: Stroke (heart beat)


subject: UNII:IY90U61Z3S

object_name: Stroke, CTCAE


subject: UNII:IY90U61Z3S

object_name: brain ischemia


subject: UNII:IY90U61Z3S

object_name: cerebral infarction


subject: UNII:0DW7MIH1VX

subject_name: Argatroban


subject: UNII:0DW7MIH1VX


subject: UNII:0DW7MIH1VX


subject: UNII:0DW7MIH1VX


subject: UNII:0DW7MIH1VX


subject: CHEBI:48720

subject_name: argatroban


subject: CHEBI:48720


subject: CHEBI:48720


subject: CHEBI:48720


subject: CHEBI:48720


subject: CHEBI:4670

subject_name: Dobutamine

object_name: hypertrophic cardiomyopathy


subject: HMDB:HMDB0041300

subject_name: PRE


subject: CHEBI:177605

subject_name: Samidorphan

object_name: binge eating


subject: CHEBI:36796

subject_name: duloxetine

object_name: interstitial lung disease


subject: UNII:68AYS9A614

subject_name: CEDIRANIB MALEATE

object_name: metastatic malignant neoplasm in the brain


subject: UNII:68AYS9A614

object_name: Metastatic Cutaneous Melanoma


subject: UMLS:C2711999

subject_name: cediranib maleate


subject: UMLS:C2711999


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: cellular diagnosis, adult acute myeloid leukemia


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: UMLS:C5554948

object_name: lung cancer


subject: UMLS:C5554948

object_name: lung neoplasm


subject: UMLS:C5554948

object_name: lung carcinoma


subject: UNII:0CA0VSF91Y

subject_name: DEURUXOLITINIB

object_name: alopecia areata


subject: UNII:0CA0VSF91Y

object_name: alopecia


subject: CHEBI:52717

subject_name: Bortezomib

object_name: systolic heart failure


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: scrub typhus


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: UMLS:C1527110

subject_name: Biobran

object_name: chronic hepatitis C virus infection


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Rare Diseases


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UMLS:C1948073


subject: CHEBI:15365

subject_name: Aspirin

object_name: nasopharyngeal carcinoma


subject: CHEBI:15365

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UNII:PP0SHH6V16

subject_name: Alirocumab

object_name: inherited lipid metabolism disorder


subject: CHEBI:2704

subject_name: Anastrozole

object_name: Prader-Willi syndrome


subject: CHEBI:2704

object_name: Silver-Russell syndrome


subject: CHEMBL.COMPOUND:CHEMBL2108621

subject_name: MAPATUMUMAB

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan

object_name: Lack of Expression of PD-L1


subject: PUBCHEM.COMPOUND:6912

subject_name: Xylitol

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:6912

object_name: Insulin resistance


subject: PUBCHEM.COMPOUND:6912

object_name: Body Composition


subject: CHEBI:17151


subject: CHEBI:17151


subject: CHEBI:17151


subject: CHEBI:228302

subject_name: Zuranolone

object_name: Post stroke depression


subject: UMLS:C1541478

subject_name: Astuprotimut-R

object_name: melanoma


subject: CHEBI:36704

subject_name: Imiquimod

object_name: vaginitis


subject: CHEBI:36704

object_name: Vaginal Inflammation, CTCAE


subject: CHEBI:36704

object_name: infective vaginitis


subject: CHEBI:53774

subject_name: tergitol


subject: CHEBI:53774


subject: CHEBI:53774


subject: CHEBI:53775


subject: CHEBI:53775


subject: CHEBI:53775


subject: CHEBI:18295

subject_name: Histamine

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:18295

object_name: acute myeloid leukemia


subject: CHEBI:231614

subject_name: Nivolumab

object_name: childhood malignant neoplasm


subject: UMLS:C2346820


subject: DRUGBANK:DB17362

subject_name: Obecabtagene autoleucel

object_name: EXCESS LMW-DNA


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: left ventricular mass


subject: CHEBI:30314

object_name: coronary artery disorder


subject: CHEBI:30314

object_name: coronary atherosclerosis


subject: CHEBI:17460

subject_name: Thioctamide


subject: CHEBI:17460


subject: CHEBI:17460


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:16494


subject: CHEBI:16494


subject: UMLS:C1529740

subject_name: Protollin

object_name: Alzheimer disease


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Headache


subject: CHEBI:60802

object_name: Headache, CTCAE


subject: UMLS:C3537187

subject_name: Biguanide [EPC]

object_name: type 2 diabetes mellitus


subject: CHEBI:60370

subject_name: (R)-etodolac

object_name: plasma cell myeloma


subject: DRUGBANK:DB18776


subject: CHEBI:95165

object_name: Refractory High Risk Myelodysplastic Syndrome


subject: CHEBI:95165

object_name: Recurrent High Risk Myelodysplastic Syndrome


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PUBCHEM.COMPOUND:5458171

subject_name: MITOXANTRONE HYDROCHLORIDE


subject: PUBCHEM.COMPOUND:5458171


subject: PUBCHEM.COMPOUND:5458171

object_name: mixed phenotype acute leukemia


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: CHEBI:50729


subject: CHEBI:191070

subject_name: nor-NOHA


subject: CHEBI:191070


subject: CHEBI:191070


subject: UMLS:C4519132


subject: UMLS:C4519132


subject: UMLS:C4519132


subject: CHEBI:135901

subject_name: lanreotide

object_name: diarrhea


subject: CHEBI:135901

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:135901

object_name: Diarrhea, CTCAE


subject: UMLS:C0051846

subject_name: angiopeptin


subject: UMLS:C0051846


subject: UMLS:C0051846


subject: CHEBI:59113


subject: CHEBI:59113

object_name: Diabetes


subject: CHEBI:59113

object_name: diabetes mellitus


subject: CHEBI:32991


subject: CHEBI:32991


subject: CHEBI:32991


subject: UMLS:C3827169

object_name: myelodysplastic syndrome with excess blasts-2


subject: UMLS:C3827168


subject: CHEBI:145374

subject_name: Enasidenib


subject: PUBCHEM.COMPOUND:78140854

subject_name: Ivosidenib


subject: UMLS:C3257082

subject_name: Fish extract

object_name: Other specified diseases of hair and hair follicles


subject: UMLS:C3257082

object_name: osteoarthritis, knee


subject: UMLS:C3257082

object_name: Trachyonychia


subject: UMLS:C3257082

object_name: Fragile nails


subject: UMLS:C3257082

object_name: Brittle nails


subject: PR:000014829

subject_name: SH3 and PX domain-containing protein 2A


subject: PR:000014829


subject: PR:000014829


subject: PR:000014829


subject: PR:000014829


subject: CHEBI:231087

subject_name: Trilaciclib

object_name: Myelosuppression adult


subject: CHEBI:60791

subject_name: Xylocard

object_name: colorectal cancer


subject: CHEBI:60791

object_name: colorectal carcinoma


subject: CHEBI:60791

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:60791

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: CHEBI:60791

object_name: neuropathy, painful


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:6456


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: fallopian tube neoplasm


subject: CHEBI:41879

object_name: peritoneal neoplasm


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN


subject: PUBCHEM.COMPOUND:49865963


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: PUBCHEM.COMPOUND:3199


subject: CHEBI:32296

subject_name: vinorelbine L-tartrate

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:32296

object_name: Embolism, Tumor


subject: CHEBI:32296

object_name: Neoplasm Metastasis


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: CHEBI:53750

subject_name: vinorelbine D-tartrate


subject: CHEBI:53750


subject: CHEBI:53750


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: PUBCHEM.COMPOUND:44424639


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:15365

subject_name: Aspirin

object_name: Recurrence


subject: CHEBI:15365

object_name: Recurrent Malignant Neoplasm


subject: CHEBI:15365

object_name: Recurrent disease


subject: CHEBI:15365

object_name: Recurrent tumor


subject: MESH:C000716647

object_name: Chronic small plaque psoriasis


subject: CHEBI:131166

subject_name: Berzosertib

object_name: small cell carcinoma


subject: CHEBI:131166

object_name: small cell lung carcinoma


subject: CHEBI:231696

object_name: neuroendocrine neoplasm


subject: CHEBI:231696

object_name: pancreatic neuroendocrine tumor


subject: CHEBI:231696

object_name: Neuroendocrine tumor of pancreas


subject: CHEBI:231696

object_name: Childhood Solid Neoplasm


subject: CHEBI:231696

object_name: Adult Solid Neoplasm


subject: CHEBI:231696

object_name: Solid Neoplasm


subject: PR:000006746

subject_name: dual specificity protein phosphatase 2


subject: PR:000006746


subject: PR:000006746


subject: PR:000006746


subject: PR:000006746


subject: PR:000006746


subject: PR:000013397

subject_name: proteasome assembly chaperone 1


subject: PR:000013397


subject: PR:000013397


subject: PR:000013397


subject: PR:000013397


subject: PR:000013397


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: polyp of large intestine


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UMLS:C5556650

subject_name: HIF2alpha Inhibitor DFF332

object_name: renal cell carcinoma


subject: UNII:N5UK68MGDZ

subject_name: Apremilast

object_name: frontal fibrosing alopecia


subject: GTOPDB:7988

subject_name: nimotuzumab

object_name: Nasopharyngeal cancer recurrent


subject: UNII:6NS400BXKH


subject: UMLS:C1570308


subject: CHEBI:9679

object_name: White Spot Lesion


subject: CHEBI:9679

object_name: Tooth Demineralization


subject: CHEBI:9679

object_name: dental caries


subject: CHEBI:9679

object_name: Dental Caries, CTCAE


subject: UMLS:C5669917

subject_name: Zirconium Zr 89-DFO-YS5

object_name: plasma cell myeloma


subject: CHEBI:15927

subject_name: Nicotinamide riboside

object_name: mild neurocognitive disorder


subject: CHEBI:15927

object_name: mild cognitive impairment


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: Locally Advanced Malignant Solid Neoplasm


subject: UNII:GKF8S4C432

object_name: Disseminated Malignant Neoplasm


subject: UNII:GKF8S4C432

object_name: Embolism, Tumor


subject: UNII:GKF8S4C432

object_name: Neoplasm Metastasis


subject: CHEBI:90943

subject_name: Osimertinib


subject: UMLS:C3536985

subject_name: gimeracil + oteracil potassium + tegafur

object_name: Metastatic malignant neoplasm to peritoneum


subject: UMLS:C3536985

object_name: gastric neoplasm


subject: UNII:C9H2L21V7U

subject_name: SMOFlipid

object_name: Reperfusion Injury


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: uterine cancer


subject: UNII:28X28X9OKV

object_name: tumor of uterus


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C1527991

subject_name: Vigil

object_name: Childhood Breast Carcinoma


subject: UMLS:C1527991

object_name: breast carcinoma


subject: UMLS:C1527991

object_name: breast cancer


subject: UMLS:C1527991

object_name: endometrial cancer


subject: UMLS:C1527991

object_name: uterine corpus cancer


subject: UMLS:C1527991

object_name: endometrial carcinoma


subject: UMLS:C1527991

object_name: fallopian tube carcinoma


subject: UMLS:C1527991

object_name: fallopian tube cancer


subject: UMLS:C1527991

object_name: primary peritoneal carcinoma


subject: UMLS:C1527991

object_name: papillary serous cystadenocarcinoma


subject: UMLS:C1527991

object_name: peritoneal carcinoma


subject: CHEBI:31859

subject_name: Modafinil


subject: CHEBI:31859


subject: CHEBI:31859


subject: CHEBI:31859


subject: CHEBI:31859


subject: CHEBI:31859


subject: CHEBI:31859


subject: CHEBI:31859


subject: UMLS:C5565538

subject_name: mazdutide

object_name: Overweight and obesity


subject: MESH:C506920

subject_name: bicarbonated Ringer's solution

object_name: septic shock


subject: UMLS:C1690922


subject: UNII:8F63U28T2V

subject_name: Imexon

object_name: melanoma


subject: CHEBI:5296

subject_name: Gemfibrozil

object_name: alcohol abuse


subject: CHEBI:5296

object_name: alcohol dependence


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: sarcoidosis


subject: UNII:4F4X42SYQ6

object_name: sarcoidosis, susceptibility to, 1


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: mild neurocognitive disorder


subject: PUBCHEM.COMPOUND:73151030

object_name: mild cognitive impairment


subject: PUBCHEM.COMPOUND:57389748

subject_name: Linagliptin


subject: PUBCHEM.COMPOUND:57389748


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE


subject: PUBCHEM.COMPOUND:155543961


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: DRUGBANK:DB10533

subject_name: Grape

object_name: Blood Pressure Finding


subject: DRUGBANK:DB10533

object_name: Systemic arterial pressure


subject: DRUGBANK:DB10533

object_name: Increased reactive oxygen species production


subject: DRUGBANK:DB10533

object_name: hyperlipidemia


subject: DRUGBANK:DB10533

object_name: hyperlipoproteinemia


subject: DRUGBANK:DB10533

object_name: Hyperlipidemia, CTCAE


subject: DRUGBANK:DB10533

object_name: Serum lipids high (finding)


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS

object_name: Hyperactivity


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:93776

subject_name: Pevonedistat

object_name: myelofibrosis


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: peripheral vascular disease


subject: UNII:1C6V77QF41

object_name: peripheral arterial disease


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C0724422

subject_name: Xylocaine 10% Oral

object_name: Cannula site pain


subject: CHEBI:46026

subject_name: North-methanocarbathymidine

object_name: poisoning


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: osteoarthritis susceptibility 6


subject: UMLS:C2987409

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C2987409

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:23080

subject_name: cerotoyl group

object_name: pancreatic neoplasm


subject: CHEBI:23080

object_name: exocrine pancreatic carcinoma


subject: CHEBI:23080

object_name: malignant pancreatic neoplasm


subject: PR:000015192

subject_name: sodium- and chloride-dependent creatine transporter 1


subject: PR:000015192


subject: PR:000015192


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: adrenal carcinoma


subject: CHEBI:46692

object_name: Infection


subject: CHEBI:46692

object_name: infectious disease


subject: CHEBI:46692

object_name: Adverse Event Associated with Infection


subject: CHEBI:46692

object_name: Sepsis


subject: CHEBI:46692

object_name: Sepsis, CTCAE


subject: CHEBI:46692

object_name: systemic inflammatory response syndrome


subject: CHEBI:46692

object_name: septic shock


subject: UNII:96265TNH2R

subject_name: Gedatolisib

object_name: non-small cell lung carcinoma


subject: UNII:8375F9S90C

subject_name: Pamiparib

object_name: Metastatic castration-resistant prostate cancer


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: esophageal disorder


subject: CHEBI:3160

object_name: Delayed gastric emptying following procedure


subject: CHEBI:3160

object_name: Achalasia


subject: UMLS:C5785437

subject_name: TLR7 Agonist CAN1012

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5785437

object_name: Embolism, Tumor


subject: CHEBI:65173

subject_name: Iloperidone

object_name: bipolar disorder


subject: CHEBI:74750

subject_name: Phe-Pro

object_name: Injury of gastrointestinal tract


subject: CHEBI:74750

object_name: acute mountain sickness


subject: PR:000014563

subject_name: succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial


subject: PR:000014563


subject: PUBCHEM.COMPOUND:22023730

subject_name: Ganaxolone

object_name: endogenous depression


subject: PUBCHEM.COMPOUND:22023730

object_name: major depressive disorder


subject: MESH:C000721867

subject_name: COVI-VAC

object_name: severe acute respiratory syndrome (SARS) pneumonia


subject: MESH:C000721867

object_name: viral pneumonia


subject: PUBCHEM.COMPOUND:67036325

subject_name: Danoprevir


subject: UNII:HD4QV8GX26

subject_name: Mesdopetam

object_name: Parkinson disease


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b

object_name: liver cirrhosis


subject: UMLS:C0021735

subject_name: Viraferon


subject: UNII:T9FVH03HMZ

subject_name: Calaspargase pegol

object_name: acute myeloid leukemia by FAB classification


subject: UNII:T9FVH03HMZ

object_name: acute myeloid leukemia


subject: CHEBI:91393

subject_name: glesatinib

object_name: non-small cell lung carcinoma


subject: CHEBI:197437

subject_name: Mocetinostat


subject: UMLS:C5561179

subject_name: ropeginterferon alfa-2b-njft

object_name: acquired polycythemia vera


subject: CHEBI:39867

subject_name: Valproic acid

object_name: intermittent explosive disorder


subject: CHEBI:5118

subject_name: Fluoxetine


subject: UMLS:C3493834

object_name: rheumatoid arthritis


subject: CHEBI:167204

subject_name: Mosapride

object_name: Gastroparesis due to diabetes mellitus


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: ovarian disease


subject: UNII:2S9ZZM9Q9V

object_name: Homologous Recombination Deficiency


subject: UNII:2S9ZZM9Q9V

object_name: malignant endocrine neoplasm


subject: UNII:2S9ZZM9Q9V

object_name: endocrine gland neoplasm


subject: UNII:2S9ZZM9Q9V

object_name: endocrine system disorder


subject: UNII:2S9ZZM9Q9V

object_name: female reproductive system neoplasm


subject: UNII:2S9ZZM9Q9V

object_name: female reproductive system disorder


subject: UNII:2S9ZZM9Q9V

object_name: Neoplasm of the genitourinary tract


subject: UNII:2S9ZZM9Q9V

object_name: gonadal disease


subject: UNII:2S9ZZM9Q9V

object_name: Adnexal Diseases


subject: UNII:2S9ZZM9Q9V

object_name: BRCA2 gene mutation


subject: UNII:2S9ZZM9Q9V

object_name: BRCA1 gene mutation


subject: CHEBI:177298

object_name: fallopian tube neoplasm


subject: CHEBI:177298


subject: CHEBI:177298

object_name: Epithelioma


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298

object_name: Neoplasms by Histologic Type


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: GTOPDB:12989

subject_name: toripalimab

object_name: hypopharyngeal carcinoma


subject: GTOPDB:12989

object_name: hypopharynx cancer


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: CHEBI:63629

subject_name: Tizanidine

object_name: Post-Operative Pain


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: cardiovascular disorder


subject: CHEBI:7421

subject_name: NAC


subject: CHEBI:7421

object_name: hypertension


subject: CHEBI:7421

object_name: Hypertension, CTCAE


subject: MESH:D002136

subject_name: Calcium, Dietary

object_name: eclampsia


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:22984

subject_name: Calcium


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: CHEBI:151315

subject_name: Heparin

object_name: female reproductive organ cancer


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: KEGG.COMPOUND:C00374


subject: UNII:YZS3R7LP44

subject_name: Palonosetron

object_name: Idiopathic scoliosis and kyphoscoliosis


subject: UNII:YZS3R7LP44

object_name: idiopathic scoliosis


subject: PR:000001151

subject_name: Toll-like receptor 1

object_name: skin melanoma


subject: CHEBI:8024

subject_name: Perindopril

object_name: Diastolic dysfunction


subject: CHEBI:8024

object_name: Heart Failure, CTCAE


subject: CHEBI:37845

subject_name: growth hormone

object_name: gastroparesis


subject: CHEBI:37845

object_name: Gastroparesis, CTCAE


subject: PUBCHEM.COMPOUND:170907453

subject_name: Growth hormone


subject: PUBCHEM.COMPOUND:170907453


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin


subject: UNII:NQX9KB6PCL


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0169964


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: UMLS:C0037663


subject: PR:000007968

subject_name: somatotropin


subject: PR:000007968


subject: CHEBI:6520

subject_name: Lomustine

object_name: ependymoma


subject: CHEBI:6520

object_name: childhood ependymoma


subject: CHEBI:6520

object_name: Newly Diagnosed Childhood Ependymoma


subject: CHEBI:6520

object_name: Adult Ependymoma


subject: CHEBI:6520

object_name: diffuse midline glioma, H3 K27M-mutant


subject: CHEBI:6520

object_name: diffuse intrinsic pontine glioma


subject: PUBCHEM.COMPOUND:2269

object_name: SARS-associated coronavirus as cause of disease classified elsewhere


subject: PUBCHEM.COMPOUND:2269

object_name: severe acute respiratory syndrome (SARS) pneumonia


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: CHEBI:31781

subject_name: Lopinavir


subject: CHEBI:31781


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:45409


subject: CHEBI:5801

subject_name: Hydroxychloroquine


subject: CHEBI:5801


subject: CHEBI:177298

object_name: metastatic prostate carcinoma


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:10125

subject_name: Zolpidem

object_name: Alzheimer disease


subject: CHEBI:3757

subject_name: Clonidine

object_name: Symptomatic irreversible pulpitis


subject: CHEBI:68647

subject_name: Regorafenib

object_name: anaplastic meningioma


subject: CHEBI:68647

object_name: grade III meningioma


subject: CHEBI:132922

object_name: Rotator cuff tear arthropathy


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: UMLS:C2347055

subject_name: Manuka Honey

object_name: Neck Carcinoma


subject: UMLS:C2347055

object_name: head and neck neoplasm


subject: UMLS:C2347055

object_name: head and neck cancer


subject: PUBCHEM.COMPOUND:129887057

object_name: arteriosclerosis disorder


subject: PUBCHEM.COMPOUND:129887057

object_name: atherosclerosis


subject: PUBCHEM.COMPOUND:129887057

object_name: Cognitive impairment


subject: PUBCHEM.COMPOUND:129887057

object_name: aneurysm


subject: UNII:K6396E6G8G


subject: UNII:K6396E6G8G


subject: UNII:K6396E6G8G


subject: UNII:K6396E6G8G


subject: UNII:7P55415B0R


subject: UNII:7P55415B0R


subject: UNII:7P55415B0R


subject: UNII:7P55415B0R


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Clinical Stage II Gastric Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Clinical Stage I Gastric Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Clinical Stage III Gastric Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Clinical Stage IVA Gastric Cancer AJCC v8


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:31348

object_name: Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4672

subject_name: Docetaxel


subject: UNII:N5UK68MGDZ

subject_name: Apremilast

object_name: ankylosing spondylitis


subject: UMLS:C3252109

subject_name: TAK 385

object_name: uterine fibroid


subject: UMLS:C0306884

subject_name: Mycostatin Oral Suspension

object_name: Anastomotic Leak


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Distal Radius Fractures


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UMLS:C5552950

subject_name: Ciclopirox Prodrug CPX-POM

object_name: bladder tumor


subject: UMLS:C5552950

object_name: urinary bladder carcinoma


subject: UMLS:C5552950

object_name: urinary bladder cancer


subject: UMLS:C5552950

object_name: childhood bladder carcinoma


subject: CHEBI:6129

subject_name: Ketorolac

object_name: female infertility


subject: CHEBI:6129

object_name: infertility


subject: UMLS:C0146226

subject_name: Toradol


subject: UMLS:C0146226


subject: UMLS:C2987420

subject_name: anrukinzumab

object_name: asthma


subject: MESH:C042973

subject_name: K-Y jelly

object_name: duration of labor (history)


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: myalgic encephalomeyelitis/chronic fatigue syndrome


subject: CHEBI:60648

object_name: Q fever


subject: CHEBI:60648

object_name: Infection caused by Coxiella


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Anal squamous cell carcinoma metastatic


subject: CHEBI:231614

object_name: Recurrent Anal Squamous Cell Carcinoma


subject: CHEBI:231614

object_name: Unresectable Anal Squamous Cell Carcinoma


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C5434105

subject_name: Injection, sacituzumab govitecan-hziy, 2.5 mg

object_name: Metastatic urothelial carcinoma


subject: UMLS:C5706412

subject_name: Pegylated TOP1 Inhibitor PEEL-224

object_name: Recurrent Rhabdomyosarcoma


subject: UMLS:C5706412

object_name: Refractory Rhabdomyosarcoma


subject: UMLS:C5706412

object_name: Refractory Neuroblastoma


subject: UMLS:C5706412

object_name: Neuroblastoma recurrent


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Renal dysfunction


subject: CHEBI:7465

subject_name: Naltrexone

object_name: Human Immunodeficiency Virus Positive


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: urgency urinary incontinence


subject: CHEBI:3160

object_name: Urinary Urgency, CTCAE


subject: CHEBI:3160

object_name: Overactive Detrusor


subject: CHEBI:80343

subject_name: Mecasermin

object_name: Noonan syndrome


subject: CHEBI:80343

object_name: Noonan syndrome 1


subject: UMLS:C4305866


subject: UMLS:C4305866


subject: CHEBI:18170

subject_name: Selenic acid

object_name: endocrine exophthalmos


subject: CHEBI:77775

subject_name: sodium selenate


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Non-small cell lung cancer stage III


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C2917334

subject_name: Calcium-sensing Receptor Agonist

object_name: secondary hyperparathyroidism


subject: PUBCHEM.COMPOUND:91864521

subject_name: Hepcidin

object_name: anemia


subject: PUBCHEM.COMPOUND:91864521

object_name: Anemia, CTCAE


subject: PUBCHEM.COMPOUND:91864521

object_name: Critical Illness


subject: UNII:XUH21YGS7O

subject_name: HEPCIDIN


subject: UNII:XUH21YGS7O


subject: UNII:XUH21YGS7O


subject: UNII:2S27T3DSZ3

object_name: Raynaud disease


subject: UNII:2S27T3DSZ3

object_name: peripheral vascular disease


subject: UMLS:C3641087

object_name: chromosome 17p deletion


subject: MESH:C000706548

object_name: gout


subject: MESH:C000706548

object_name: Hyperuricemia


subject: MESH:C000706548

object_name: Hyperuricemia, CTCAE


subject: CHEBI:90942

subject_name: Ixazomib

object_name: Refractory acute myeloid leukemia


subject: GTOPDB:12989

subject_name: toripalimab

object_name: Nasopharyngeal cancer recurrent


subject: GTOPDB:12989

object_name: Effects of chemotherapy


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UMLS:C3641686

subject_name: Technetium Tc 99m-3PRGD2

object_name: lung cancer


subject: UMLS:C3641686

object_name: lung neoplasm


subject: UMLS:C3641686

object_name: lung carcinoma


subject: CHEBI:38108

subject_name: azetidine-2-carboxylic acid

object_name: Myelodysplasia


subject: CHEBI:38108

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:38108

object_name: childhood myelodysplastic syndrome


subject: CHEBI:38108

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:38108

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:38108

object_name: Secondary Myelodysplastic Syndrome


subject: CHEBI:38108

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:38108

object_name: chronic myelomonocytic leukemia


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Pancreatic carcinoma non-resectable


subject: PUBCHEM.COMPOUND:2269

object_name: meningococcal infection


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:9150

subject_name: Simvastatin

object_name: triple-negative breast carcinoma


subject: CHEBI:9150

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:9150

object_name: Adverse reaction caused by simvastatin


subject: CHEBI:9150

object_name: Effects of chemotherapy


subject: GTOPDB:13450

subject_name: briquilimab

object_name: allergic asthma


subject: UNII:QWX84D0DRC

subject_name: BRIQUILIMAB


subject: UMLS:C5418059

subject_name: AMG 191


subject: UNII:513P80B4YJ

subject_name: Avapritinib

object_name: central nervous system neoplasm


subject: UNII:513P80B4YJ

object_name: central nervous system cancer


subject: UNII:513P80B4YJ

object_name: Recurrent Malignant Solid Neoplasm


subject: UNII:513P80B4YJ

object_name: unspecified childhood solid tumor, protocol specific


subject: UMLS:C3540580

subject_name: Tocotrienol-rich Fraction

object_name: Malignant neoplasm of female breast


subject: CHEBI:35940

subject_name: Protirelin


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Unresectable Colorectal Adenocarcinoma


subject: UNII:MH5DMF9JKY

subject_name: Emavusertib

object_name: Metastatic Colorectal Adenocarcinoma


subject: UNII:MH5DMF9JKY

object_name: Stage IV Colorectal Cancer AJCC v8


subject: UNII:MH5DMF9JKY

object_name: Stage III Colorectal Cancer AJCC v8


subject: UNII:MH5DMF9JKY


subject: PUBCHEM.COMPOUND:118224238


subject: PUBCHEM.COMPOUND:118224238


subject: PUBCHEM.COMPOUND:118224238


subject: PUBCHEM.COMPOUND:118224238


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:15640

subject_name: Leucovorin


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: PUBCHEM.COMPOUND:2863

object_name: congenital adrenal hyperplasia


subject: CHEBI:230791

subject_name: tributyrylglycerol

object_name: urolithiasis


subject: CHEBI:35020

subject_name: Tributyrin


subject: UMLS:C4331211

object_name: cancer


subject: UMLS:C4331211

object_name: neoplasm


subject: PUBCHEM.COMPOUND:147912

subject_name: Posaconazole

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: PUBCHEM.COMPOUND:147912

object_name: aplastic anemia


subject: PUBCHEM.COMPOUND:147912

object_name: idiopathic aplastic anemia


subject: CHEBI:9014

subject_name: Salsalate

object_name: HIV infection


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:21879648

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:21879648

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: castration-resistant prostate carcinoma


subject: UMLS:C4684819

subject_name: Wnt Signaling Pathway Inhibitor SM08502


subject: UMLS:C4684819

object_name: non-small cell lung carcinoma


subject: UMLS:C4684819


subject: UMLS:C4684819


subject: UMLS:C4684819


subject: DRUGBANK:DB17512

object_name: cervical cancer


subject: DRUGBANK:DB17512

object_name: cervical carcinoma


subject: UMLS:C4722726

object_name: hepatobiliary disorder


subject: UMLS:C4722726

object_name: liver disorder


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Injection site irritation


subject: CHEBI:74705

object_name: Injection site bruising


subject: CHEBI:74705

object_name: Injection site discomfort


subject: CHEBI:74705

object_name: Benzoic acid adverse reaction


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:26710


subject: CHEBI:26710


subject: CHEBI:26710


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: COPD exacerbation


subject: CHEBI:8378

subject_name: Prednisolone

object_name: Esophageal stenosis


subject: CHEBI:8378

object_name: Esophageal Stenosis, CTCAE


subject: CHEBI:8378

object_name: Barrett esophagus


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: BRCA1 gene mutation


subject: MESH:C000601293

object_name: type 2 diabetes mellitus


subject: CHEBI:50853

subject_name: quantum dot

object_name: hypertension


subject: CHEBI:50853

object_name: Hypertension, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL2108045

subject_name: PRITUMUMAB

object_name: brain cancer


subject: CHEMBL.COMPOUND:CHEMBL2108045

object_name: Metastatic Adult Malignant Neoplasm in the Brain


subject: UMLS:C5417802

subject_name: Pritumumab


subject: UMLS:C5417802


subject: UMLS:C3896812

object_name: adult liposarcoma


subject: UMLS:C3896812

object_name: liposarcoma


subject: UMLS:C3896812

object_name: pediatric liposarcoma


subject: UMLS:C3896812

object_name: Liposarcoma metastatic


subject: UNII:510M006KO6

subject_name: Eltoprazine

object_name: Cognitive impairment


subject: UNII:510M006KO6

object_name: schizophrenia


subject: UNII:LIA7Z4002P

subject_name: Nadroparin

object_name: cancer


subject: UNII:LIA7Z4002P

object_name: neoplasm


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: vision disorder


subject: UMLS:C5963450

object_name: ovarian cancer


subject: UMLS:C5963450

object_name: ovarian neoplasm


subject: UMLS:C5963450

object_name: ovarian carcinoma


subject: DRUGBANK:DB16497

object_name: cystic fibrosis


subject: UMLS:C0591758

subject_name: Maxtrex

object_name: Nasal Polyp


subject: UMLS:C0591758

object_name: Multiple polyps of nasal cavity and/or nasal sinus


subject: UNII:O2Z8Q22ZE4

subject_name: Cavosonstat

object_name: asthma


subject: GTOPDB:9195

subject_name: clazakizumab


subject: UNII:4S38Z8RA9O


subject: UMLS:C2830049


subject: DRUGBANK:DB13959

subject_name: Medium-chain triglycerides


subject: PR:000010231

subject_name: malonyl-CoA-acyl carrier protein transacylase, mitochondrial


subject: PR:000022561

subject_name: malonyl CoA-acyl carrier protein transacylase


subject: PR:000023036


subject: CHEBI:94534

subject_name: olanzapine

object_name: Acute schizophrenia


subject: CHEBI:6715

subject_name: medroxyprogesterone

object_name: Childhood Breast Carcinoma


subject: CHEBI:6715

object_name: breast carcinoma


subject: CHEBI:6715

object_name: breast cancer


subject: CHEBI:6715

object_name: uterine corpus cancer


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: colorectal cancer


subject: CHEBI:3311

object_name: colorectal carcinoma


subject: CHEBI:3311

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:3311

object_name: polyp


subject: CHEBI:3311

object_name: adenoma


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: DRUGBANK:DB16537

subject_name: Bacillus clausii

object_name: Respiratory infections in children


subject: UMLS:C0383956

subject_name: HBOC 201

object_name: coronary artery disorder


subject: UMLS:C0383956

object_name: coronary atherosclerosis


subject: CHEMBL.COMPOUND:CHEMBL2108603

subject_name: HEMOGLOBIN GLUTAMER-250 (BOVINE)


subject: CHEMBL.COMPOUND:CHEMBL2108603


subject: UNII:1XQE66T19H


subject: UNII:1XQE66T19H


subject: UMLS:C5238017

subject_name: Hemoglobin glutamer-250 (bovine)


subject: UMLS:C5238017


subject: CHEBI:9398

subject_name: Tamsulosin

object_name: urinary tract infection


subject: CHEBI:9398

object_name: Recurrent urinary tract infections


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: squamous cell neoplasm


subject: PUBCHEM.COMPOUND:14907381

object_name: basal cell neoplasm


subject: PUBCHEM.COMPOUND:14907381

object_name: skin disorder


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: GTOPDB:9202

subject_name: setrusumab

object_name: osteogenesis imperfecta type 1


subject: GTOPDB:9202

object_name: osteogenesis imperfecta type 3


subject: GTOPDB:9202

object_name: osteogenesis imperfecta type 4


subject: CHEMBL.COMPOUND:CHEMBL4297918

subject_name: SETRUSUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297918


subject: CHEMBL.COMPOUND:CHEMBL4297918


subject: UMLS:C4726749


subject: UMLS:C4726749


subject: UMLS:C4726749


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID


subject: UNII:6XC1PAD3KF


subject: UNII:6XC1PAD3KF


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: CHEBI:46557


subject: MESH:D004043

subject_name: Dietary Fiber

object_name: Abdominal obesity


subject: MESH:D004043

object_name: Truncal obesity


subject: CHEBI:15551

subject_name: Dinoprostone

object_name: Uses contraception (finding)


subject: UMLS:C2587184

subject_name: Parenogen

object_name: Alloimmune platelet transfusion refractoriness


subject: UNII:3ZY6J6Z6EE

subject_name: Droxidopa

object_name: fibromyalgia


subject: CHEBI:3395

subject_name: carbidopa


subject: CHEBI:94430

subject_name: DL-Carbidopa


subject: CHEBI:39585

subject_name: Carbidopa


subject: PUBCHEM.COMPOUND:45382195

subject_name: Thymosin Beta 4

object_name: decubitus ulcer


subject: UMLS:C0076616

subject_name: Thymosin beta-4


subject: CHEBI:50172

subject_name: acitretin

object_name: Psoriasis, skin or nails


subject: CHEBI:50174


subject: UNII:LDJ89SS0YG

subject_name: Mosunetuzumab

object_name: Hodgkin Disease


subject: UNII:LDJ89SS0YG

object_name: Adult Hodgkin Lymphoma


subject: UNII:LDJ89SS0YG

object_name: Childhood Hodgkin Lymphoma


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UNII:QQA9MLH692

subject_name: Tafasitamab

object_name: B-cell non-Hodgkin lymphoma


subject: UNII:QQA9MLH692


subject: UNII:QQA9MLH692


subject: UNII:QQA9MLH692


subject: UMLS:C2987409


subject: UMLS:C2987409


subject: UMLS:C2987409


subject: UMLS:C2987409


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:233362

object_name: Metastatic Soft Tissue Sarcoma


subject: CHEBI:233362

object_name: Advanced Leiomyosarcoma


subject: CHEBI:233362

object_name: Metastatic Dedifferentiated Liposarcoma


subject: CHEBI:233362

object_name: Advanced Soft Tissue Sarcoma


subject: CHEBI:233362

object_name: Metastatic leiomyosarcoma


subject: CHEBI:233362

object_name: Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


subject: CHEBI:233362

object_name: Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Tendon Injuries


subject: CHEBI:65265

subject_name: antacid

object_name: Heartburn


subject: UMLS:C0003138

subject_name: Antacids


subject: UMLS:C5962599

subject_name: Anti-PD-1/IL-2Ra/IL-2 Fusion Protein REGN10597

object_name: melanoma


subject: GTOPDB:10077

subject_name: tadekinig alfa

object_name: cytokine release syndrome


subject: GTOPDB:10077

object_name: hemophagocytic syndrome


subject: CHEMBL.COMPOUND:CHEMBL2108054

subject_name: TADEKINIG ALFA


subject: CHEMBL.COMPOUND:CHEMBL2108054


subject: PR:000008986

subject_name: interleukin-18-binding protein


subject: PR:000008986


subject: DRUGBANK:DB16497

object_name: severe acute respiratory syndrome


subject: CHEBI:6931

subject_name: Midazolam

object_name: Post-Dural Puncture Headaches


subject: CHEBI:6931

object_name: Lumbar Puncture Headache


subject: CHEBI:6504

object_name: borderline personality disorder


subject: CHEBI:6504

object_name: dysthymic disorder


subject: UMLS:C5783508

subject_name: Aurora A Kinase Inhibitor JAB-2485

object_name: Solid Neoplasm


subject: UMLS:C5783508

object_name: small cell lung carcinoma


subject: UMLS:C5783508

object_name: ARID1A gene mutation


subject: UMLS:C5783508

object_name: estrogen-receptor positive breast cancer


subject: UMLS:C3871731

subject_name: LumaSon KIT

object_name: tetralogy of fallot


subject: UMLS:C3871731

object_name: pulmonary valve insufficiency


subject: UMLS:C3871731

object_name: Respiratory insufficiency


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: serpiginous choroiditis


subject: UNII:2S9ZZM9Q9V

object_name: Vogt-Koyanagi-Harada disease


subject: UNII:2S9ZZM9Q9V

object_name: multifocal choroiditis


subject: CHEBI:10033

subject_name: Warfarin

object_name: COPD exacerbation


subject: CHEBI:10033

object_name: Pulmonary thromboembolism


subject: CHEBI:8871

subject_name: Risperidone

object_name: methamphetamine dependence


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Episodic Cluster Headache


subject: UMLS:C2092279

subject_name: Sodium Chloride Liquid Injection

object_name: atopic eczema


subject: CHEBI:26710

subject_name: Sodium chloride


subject: UNII:Q8L6AN59YY

subject_name: Bitopertin

object_name: schizophrenia


subject: CHEBI:90881

subject_name: Camptosar

object_name: liver cancer


subject: CHEBI:90881

object_name: liver neoplasm


subject: CHEBI:90881

object_name: Adult Liver Carcinoma


subject: UMLS:C0009906

subject_name: Combined Oral Contraceptives

object_name: Turner syndrome


subject: UMLS:C0009906

object_name: primary ovarian failure


subject: UMLS:C0009906

object_name: premature menopause


subject: UNII:KX7K68Z2UH

subject_name: ENZASTAURIN HYDROCHLORIDE

object_name: Childhood Neuroblastoma


subject: UNII:KX7K68Z2UH

object_name: neuroblastoma


subject: UMLS:C1765315

subject_name: Enzastaurin Hydrochloride


subject: UMLS:C1765315


subject: UNII:CER0OPG92L

subject_name: Abivertinib

object_name: prostate carcinoma


subject: UNII:CER0OPG92L

object_name: prostate cancer


subject: UNII:CER0OPG92L

object_name: metastatic prostate carcinoma


subject: UMLS:C5203530

subject_name: Tranexamic Acid Liquid Injection

object_name: Exsanguination


subject: UMLS:C5203530

object_name: Postoperative Hemorrhage


subject: UMLS:C5203530

object_name: arthroplasty; complications


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: toxic epidermal necrolysis


subject: UNII:PVI5M0M1GW

object_name: Rare Diseases


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PUBCHEM.COMPOUND:135351887

subject_name: PALAZESTRANT

object_name: Advanced breast cancer


subject: PUBCHEM.COMPOUND:135351887

object_name: estrogen-receptor positive breast cancer


subject: PUBCHEM.COMPOUND:135351887

object_name: Her2-receptor negative breast cancer


subject: UNII:VU35KM56Q4


subject: UNII:VU35KM56Q4


subject: UNII:VU35KM56Q4


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: Unresectable NUT Carcinoma


subject: UNII:6QVL057INT

object_name: Metastatic NUT Carcinoma


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UNII:T4H8FMA7IM

subject_name: Siltuximab

object_name: acute lymphoblastic leukemia


subject: UNII:724GKU717M

subject_name: Jojoba oil

object_name: epidermolysis bullosa simplex


subject: UNII:724GKU717M

object_name: pachyonychia congenita


subject: UMLS:C1707048

subject_name: broccoli sprout extract


subject: UMLS:C1707048


subject: UMLS:C1328655

object_name: ovarian cancer


subject: UMLS:C1328655

object_name: ovarian neoplasm


subject: UMLS:C1328655

object_name: ovarian carcinoma


subject: UMLS:C1328655

object_name: fallopian tube carcinoma


subject: UMLS:C1328655

object_name: fallopian tube cancer


subject: UMLS:C1328655

object_name: peritoneal neoplasm


subject: CHEBI:31550

subject_name: Patupilone


subject: CHEBI:31550


subject: CHEBI:31550


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: rheumatoid arthritis


subject: UMLS:C1530450

subject_name: AMG 162


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: Indolent Non-Hodgkin Lymphoma


subject: UNII:8M7YSN2KII

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UniProtKB:P15379-4


subject: UNII:KAJ2CK6ZYE

subject_name: BAVTAVIRINE

object_name: HIV-1 infection


subject: UMLS:C5909119

subject_name: Bavtavirine


subject: UMLS:C5964845

object_name: EGFR gene mutation


subject: CHEBI:42588

subject_name: Fenretinide

object_name: Stage I Adult Hodgkin Lymphoma


subject: CHEBI:42588

object_name: Stage III Adult Hodgkin Lymphoma


subject: CHEBI:42588

object_name: Stage II Adult Hodgkin Lymphoma


subject: CHEBI:42588

object_name: Mantle cell lymphoma stage III


subject: CHEBI:42588

object_name: Stage IV Adult Hodgkin Lymphoma


subject: CHEBI:42588

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:42588

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:42588

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:42588

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:42588

object_name: MALT lymphoma


subject: CHEBI:42588

object_name: extranodal marginal zone B-cell lymphoma


subject: CHEBI:42588

object_name: Ann Arbor Stage II Contiguous Mantle Cell Lymphoma


subject: CHEBI:42588

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: CHEBI:42588

object_name: Stage I Adult Diffuse Large Cell Lymphoma


subject: CHEBI:42588

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:42588

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: CHEBI:42588

object_name: Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma


subject: CHEBI:42588

object_name: B-cell small lymphocytic lymphoma stage III


subject: CHEBI:42588

object_name: adult nodular lymphocyte predominant Hodgkin lymphoma


subject: CHEBI:42588

object_name: B-cell small lymphocytic lymphoma stage I


subject: CHEBI:42588

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:42588

object_name: B-cell small lymphocytic lymphoma stage II


subject: CHEBI:42588

object_name: B-cell small lymphocytic lymphoma stage IV


subject: CHEBI:42588

object_name: Stage II Contiguous Adult Diffuse Large Cell Lymphoma


subject: CHEBI:42588

object_name: Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma


subject: CHEBI:42588

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: CHEBI:42588

object_name: Marginal zone lymphoma stage III


subject: CHEBI:42588

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:42588

object_name: Stage III Adult Burkitt Lymphoma


subject: CHEBI:42588

object_name: Stage I Adult Lymphoblastic Lymphoma


subject: CHEBI:42588

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: CHEBI:42588

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:42588

object_name: Marginal zone lymphoma stage II


subject: CHEBI:42588

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:42588

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: CHEBI:42588

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: CHEBI:42588

object_name: splenic marginal zone lymphoma


subject: CHEBI:42588

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:42588

object_name: Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma


subject: CHEBI:42588

object_name: Stage I Adult Burkitt Lymphoma


subject: CHEBI:42588

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:42588

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:42588

object_name: Stage IV Adult Burkitt Lymphoma


subject: CHEBI:42588

object_name: Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma


subject: CHEBI:42588

object_name: Ann Arbor Stage I Grade 2 Follicular Lymphoma


subject: CHEBI:42588

object_name: Ann Arbor Stage I Grade 1 Follicular Lymphoma


subject: CHEBI:42588

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:42588

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: CHEBI:42588

object_name: Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma


subject: CHEBI:42588

object_name: Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma


subject: CHEBI:42588

object_name: Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma


subject: CHEBI:42588

object_name: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma


subject: CHEBI:42588

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: CHEBI:42588

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: CHEBI:42588

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:42588

object_name: Chronic lymphocytic leukaemia stage 3


subject: CHEBI:42588

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:42588

object_name: Chronic lymphocytic leukaemia stage 2


subject: CHEBI:42588

object_name: Chronic lymphocytic leukaemia stage 4


subject: CHEBI:42588

object_name: Chronic lymphocytic leukaemia stage 1


subject: CHEBI:42588

object_name: Waldenstrom macroglobulinemia


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: extranodal marginal zone B-cell lymphoma


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:24848

subject_name: inositol

object_name: Depressed mood


subject: CHEBI:24848

object_name: Cancer patients and suicide and depression


subject: CHEBI:24848

object_name: Depressed - symptom


subject: CHEBI:24848

object_name: Depression, CTCAE


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone

object_name: osteoporosis


subject: UMLS:C4721537

object_name: Encounter due to family history of osteoporosis


subject: UMLS:C4721537

object_name: Osteoporosis, CTCAE 5.0


subject: UMLS:C4721537

object_name: Osteoporosis, CTCAE 3.0


subject: UMLS:C4045974

subject_name: Biosimilars

object_name: diabetes mellitus


subject: CHEBI:74538

subject_name: Leu-Gly-Gly

object_name: pervasive developmental disorder


subject: CHEBI:74538

object_name: autism


subject: CHEBI:74538

object_name: autism spectrum disorder


subject: CHEBI:74538

object_name: Gastrointestinal symptom


subject: UMLS:C0721277

subject_name: LGG brand of Dyphylline/Guaifenesin


subject: UMLS:C0721277


subject: UMLS:C0721277


subject: UMLS:C0721277


subject: UMLS:C1832078

subject_name: LGG Lactobacillus rhamnosus GG


subject: UMLS:C1832078


subject: UMLS:C1832078


subject: UMLS:C1832078


subject: CHEMBL.COMPOUND:CHEMBL2108661

subject_name: VEHICLE

object_name: presbyopia


subject: UMLS:C1134664

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C1134664

object_name: non-Hodgkin lymphoma


subject: UMLS:C1134664

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C1134664

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:50815

subject_name: Norgestimate

object_name: Metrorrhagia


subject: CHEBI:50815

object_name: heavy bleeding between periods (symptom)


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: lung cancer


subject: UMLS:C1527137

object_name: lung neoplasm


subject: UMLS:C1527137

object_name: lung carcinoma


subject: UMLS:C1527137

object_name: digestive system cancer


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: UNII:S7V92P67HO


subject: UMLS:C1527137

object_name: concussion


subject: CHEBI:16796


subject: CHEBI:9570

subject_name: Thiotepa

object_name: diffuse large B-cell lymphoma


subject: CHEBI:9570

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:9570

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: GTOPDB:8966

subject_name: onartuzumab

object_name: glioblastoma


subject: GTOPDB:8966

object_name: Childhood Glioblastoma


subject: GTOPDB:8966

object_name: adult glioblastoma


subject: CHEMBL.COMPOUND:CHEMBL1743051

subject_name: ONARTUZUMAB


subject: CHEMBL.COMPOUND:CHEMBL1743051


subject: CHEMBL.COMPOUND:CHEMBL1743051


subject: UMLS:C2826110


subject: UMLS:C2826110


subject: UMLS:C2826110


subject: UMLS:C4764358

object_name: COVID-19 respiratory infection


subject: PUBCHEM.COMPOUND:3367

object_name: autoimmune lymphoproliferative syndrome type 1


subject: PUBCHEM.COMPOUND:3367

object_name: autoimmune lymphoproliferative syndrome


subject: PUBCHEM.COMPOUND:3367

object_name: X-linked lymphoproliferative syndrome


subject: PUBCHEM.COMPOUND:3367

object_name: Bruton-type agammaglobulinemia


subject: PUBCHEM.COMPOUND:3367

object_name: Chediak-Higashi syndrome


subject: PUBCHEM.COMPOUND:3367

object_name: DiGeorge syndrome


subject: PUBCHEM.COMPOUND:3367

object_name: 22q11.2 deletion syndrome


subject: PUBCHEM.COMPOUND:3367

object_name: hyper-IgM syndrome


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:9570

object_name: common variable immunodeficiency


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570

object_name: severe combined immunodeficiency


subject: CHEBI:9570


subject: CHEBI:9570

object_name: chronic granulomatous disease


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570

object_name: Wiskott-Aldrich syndrome


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:67271

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:87631

subject_name: statin

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:87631

object_name: metabolic syndrome X


subject: CHEBI:87631

object_name: Sedentary lifestyle


subject: CHEBI:87631

object_name: obesity


subject: CHEBI:9150

subject_name: Simvastatin


subject: GTOPDB:12918

object_name: Crohn disease


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: Polyphagia


subject: UNII:NQX9KB6PCL

object_name: Atypical behavior


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0169964


subject: CHEBI:64019

subject_name: Nebivolol

object_name: pure autonomic failure


subject: CHEBI:64019

object_name: multiple system atrophy


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Drug toxicity


subject: UMLS:C2346820


subject: CHEBI:59163

subject_name: biomarker

object_name: diastolic heart failure


subject: CHEBI:59163

object_name: Myocardial fibrosis


subject: UMLS:C2830052

object_name: B-cell non-Hodgkin lymphoma


subject: UMLS:C2830052

object_name: B-Cell Leukemia


subject: PUBCHEM.COMPOUND:123131802

object_name: Head and neck cancer metastatic


subject: PUBCHEM.COMPOUND:123131802

object_name: Recurrent Malignant Head and Neck Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297688


subject: CHEMBL.COMPOUND:CHEMBL4297688


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin

object_name: psoriasis


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:32133

object_name: familial acute respiratory distress syndrome, ANLN-related, dog


subject: CHEBI:32133

object_name: COVID-19-Associated Acute Respiratory Distress Syndrome


subject: UNII:0CLL4232KD

subject_name: SIVELESTAT SODIUM


subject: UNII:0CLL4232KD


subject: UMLS:C2699305

subject_name: Sivelestat Sodium


subject: UMLS:C2699305


subject: UNII:J8435V445B

subject_name: Alicaforsen

object_name: ulcerative colitis


subject: UNII:J8435V445B

object_name: inflammatory bowel disease 1


subject: UMLS:C4329337

subject_name: TAB 001

object_name: Colon Neoplasm


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: Hyponatremia